{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:30:55Z","timestamp":1791869455236,"version":"4.3.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Coronary sinus (CS) lactate level has been shown to corroborate with changes in myocardial metabolism induced by ischaemia and reperfusion, and hence can be used to indicate the effect on myocardial metabolism. In patients with mitral stenosis (MS) undergoing valvuloplasty or valve replacement, presence of severe pulmonary hypertension (PH), indicates advanced disease state and development of right ventricular (RV) failure, an important hallmark of bad prognosis. Levosimendan and milrinone are increasingly being used as inodilators to treat PH and improve RV function to varying degrees, but their effect on myocardial metabolism awaits precise validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Thirty patients were randomized into two groups of 15 patients each. Group L (received levosimendan) and Group M (received milrinone). All the patients received fentanyl (8\u201310 \u03bcg\/kg), rocuronium bromide 0.8 mg\/Kg for induction and maintenance of anaesthesia. In addition to the routine intravenous and invasive arterial access, a Cavafix\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (Certo\n                      <jats:sup>\u00ae<\/jats:sup>\n                      257, 45 cm, B Braun Melsungen AG, Germany) was inserted via right IJV and positioned in the right atrium (RA) to be later re-positioned in the CS before coming off cardiopulmonary bypass (CPB), to obtain blood samples for measuring the CS lactate levels postoperatively. At the commencement of rewarming, group L received levosimendan 10 \u03bc\/kg bolus over 10 min, followed by an infusion (0.1 \u03bc\/kg\/min) and group M received 50 \u03bcg\/kg bolus over 10 min, followed by infusion (0.5 \u03bcg\/kg\/min), till 24 hours post-operatively. CS lactate, heart rate (HR), mean arterial pressure (MAP) and PA catheter derived data [Cardiac index (CI), cardiac output (CO), PA pressure, systemic and pulmonary vascular resistance indices (SVRI\/PVRI)] and mixed venous oxygen saturations (SvO2) were recorded at predetermined time points.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In both the groups the CS lactate levels increased gradually till 6 hours after surgery followed by a decrease at 24 hours. Comparison of CS lactate between the two groups revealed that the CS lactate levels were significantly lower in group L at various time points till 24 hours after surgery with a P value of &lt; 0.05. HR and MAP were comparable in both the groups at all time points. MAP was significantly lower in the two groups, both after induction of anaesthesia and after CPB. 7 patients in group M (46.7%) developed hypotension (MAP decreased by &gt; 20% of baseline) that was treated with norepinephrine. CO increased significantly in both group M and group L, post CPB 10 min after surgery. Patients in group L had a significantly higher CO and CI, compared to group M, P &lt; 0.05. PAP was significantly reduced compared to baseline values after valve replacement in both the groups being lower in group L compared to group M, but the difference was statistically not significant. After valve replacement, SVRI decreased significantly in both the group the decrease being significantly more in group L (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study revealed that, in comparison to milrinone, levosimendan was associated with comparable reduction in systolic and mean pulmonary artery pressure, lesser incidence of hypotension, lesser requirement of inotropic support and better myocardial performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aca.aca_4_25","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T12:00:52Z","timestamp":1752062452000},"page":"298-304","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous Levosimendan versus Milrinone: Coronary Sinus Lactate and PA Catheter Derived Parameters in Patients with Pulmonary Hypertension Undergoing Elective Mitral Valve Replacement"],"prefix":"10.4103","volume":"28","author":[{"given":"Sanjula","family":"Virmani","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, G B Pant Institute of Postgraduate Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdev","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, G B Pant Institute of Postgraduate Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anaesthesia, PGIMS Rohtak, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhas Chandra","family":"Dash","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anaesthesiology andIntensive Care, Manipal Hospital, Dwarka, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayyed Ehtesham Hussain","family":"Naqvi","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, G B Pant Institute of Postgraduate Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Wadhwa","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care, G B Pant Institute of Postgraduate Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, G B Pant Institute of Postgraduate Medical Education and Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"R1-20250709","first-page":"485","article-title":"Immediate and long term results of mitral balloon valvuloplasty in patients with severe pulmonary hypertension","volume":"17","author":"Fawzy","year":"2008","journal-title":"J Heart Valve Dis"},{"key":"R2-20250709","first-page":"942","article-title":"Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing balloon mitral valvotomy","volume":"13","author":"Fawzy","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"R3-20250709","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00059-016-4509-2","article-title":"Pulmonary hypertenension in rheumatic mitral stenosis","volume":"42","author":"Pourafkari","year":"2017","journal-title":"Herz"},{"key":"R4-20250709","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2016.10.047","article-title":"The relationship between the right ventricle and its load in pulmonary hypertension","volume":"69","author":"Vonk","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R5-20250709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/096721090000800101","article-title":"Postoperative acute refractory right ventricular failure: Incidence, pathogenesis, management, and prognosis","volume":"8","author":"Kaul","year":"2008","journal-title":"Cardiovasc Surg"},{"key":"R6-20250709","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1053\/j.jvca.2023.07.041","article-title":"Pulmonary vasodilator and inodilator drugs in cardiac surgery: A systematic review with Bayesian network meta-analysis","volume":"37","author":"Sardo","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R7-20250709","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1089253206294400","article-title":"Inhaled milrinone: A new alternative in cardiac surgery?","volume":"10","author":"Denault","year":"2006","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R8-20250709","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.jvca.2016.11.033","article-title":"Intratracheal milrinone bolus administration during acute right ventricular dysfunction after cardiopulmonary bypass","volume":"31","author":"Gebhard","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R9-20250709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10742484241276431","article-title":"Boosting the beat: A critical showdown of levosimendan and milrinone in surgical and non-surgical scenarios: A narrative review","volume":"29","author":"Quintero-Altare","year":"2024","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R10-20250709","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00000542-199809000-00008","article-title":"Acute depression of myocardial \u03b2-Adrenergic receptor signalling during cardiopulmonary bypass. Impairment of the Adenylyl Cyclase Moiety","volume":"89","author":"Booth","year":"1998","journal-title":"Anesthesiology"},{"key":"R11-20250709","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1248\/yakushi.127.375","article-title":"Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension","volume":"127","author":"Oztekin","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"R12-20250709","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40265-022-01833-w","article-title":"Use of levosimendan in patients with pulmonary hypertension: What is the current evidence?","volume":"83","author":"Masarone","year":"2023","journal-title":"Drugs"},{"key":"R13-20250709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2003.12.006","article-title":"Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization","volume":"486","author":"Sorsa","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R14-20250709","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.jvca.2005.01.039","article-title":"Levosimendan in severe right ventricular failure following mitral valve replacement","volume":"20","author":"Morais","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R15-20250709","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5414\/CPP40465","article-title":"Pharmacokinetics of levosimendan and its metabolites during and after a 24- h continuous infusion in patients with severe heart failure","volume":"40","author":"Kivikko","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R16-20250709","doi-asserted-by":"crossref","first-page":"S2220","DOI":"10.1016\/S0003-4975(01)03296-9","article-title":"Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites","volume":"72","author":"Crittenden","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R17-20250709","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0971-9784.185526","article-title":"Short-term prognostic value of perioperative coronary sinus-derived-serum cardiac troponin-I, Creatine kinase-MB, lactate, pyruvate, and lactate-pyruvate ratio in adult patients undergoing open heart surgery","volume":"19","author":"Chowdhury","year":"2016","journal-title":"Ann Card Anaesth"},{"key":"R18-20250709","first-page":"189","article-title":"Coronary sinus lactate as marker of myocardial ischemia in cardiac surgery: Correlation with morbidity and mortality after cardiac surgery\/Lactatul din sinusulcoronarian-marker al ischemiei miocardice \u00een chirurgia cardiac\u0103: Corelatii cu morbiditatea \u015fi mortalitatea postoperatorie","volume":"23","author":"Raicea","year":"2015","journal-title":"Rom Rev Lab Med"},{"key":"R19-20250709","first-page":"639","article-title":"Comparative effect of levosimendan and milrinone in cardiac surgery patients with pulmonary hypertension and left ventricular dysfunction","volume":"30","author":"Mishra","year":"2016","journal-title":"Anesthesia"},{"key":"R20-20250709","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0003-4975(01)02634-0","article-title":"Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery","volume":"71","author":"Rao","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R21-20250709","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejcts.2009.07.003","article-title":"NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery","volume":"37","author":"Gasparovic","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"R22-20250709","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/0970-9185.81819","article-title":"Changes in myocardial lactate, pyruvate and pyruvate-lactate ratio during cardiopulmonary bypass for elective adult cardiac surgery: Early indicator of morbidity","volume":"27","author":"Kapoor","year":"2011","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"R23-20250709","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/01.CCM.0000055390.97331.DB","article-title":"Plasminogen activator inhibitor activity is associated with raised lactate levels after cardiac surgery with cardiopulmonary bypass","volume":"31","author":"Dixon","year":"2003","journal-title":"Crit Care Med"},{"key":"R24-20250709","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2044.2006.04937.x","article-title":"Rectal lactate levels in endoluminal microdialysate during routine coronary surgery","volume":"62","author":"Solligard","year":"2007","journal-title":"Anaesthesia"},{"key":"R25-20250709","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.jvca.2017.08.002","article-title":"Prognostic value of hyperlactemia and lactate clearance after mitral valve surgery","volume":"32","author":"Evans","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R26-20250709","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1053\/j.jvca.2015.04.024","article-title":"Evaluation of serial arterial lactate levels as a predictor of hospital and long-term mortality in patients after cardiac surgery","volume":"29","author":"Lopez-Delgado","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R27-20250709","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jtcvs.2013.02.003","article-title":"High lactate levels are predictors of major complications after cardiac surgery","volume":"146","author":"Hajjar","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R28-20250709","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00003643-200109000-00004","article-title":"What factors are associated with hyperlactatemia after cardiac surgery characterized by well-maintained oxygen delivery and a normal postoperative course? A retrospective study","volume":"18","author":"Inoue","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"R29-20250709","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc4891","article-title":"The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome-A randomized controlled study [ISRCTN35655335]","volume":"10","author":"von Heymann","year":"2006","journal-title":"Crit Care"},{"key":"R30-20250709","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.jvca.2010.07.004","article-title":"Levosimendan in congenital cardiac surgery: A randomized, double-blind clinical trial","volume":"25","author":"Momeni","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R31-20250709","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1476-5381.1994.tb13143.x","article-title":"A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts","volume":"112","author":"Rump","year":"1994","journal-title":"Br J Pharmac"},{"key":"R32-20250709","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2147\/TCRM.S102772","article-title":"Cardiac, renal and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: Evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase","volume":"12","author":"Guerro-Orriach","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"R33-20250709","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.jvca.2006.02.012","article-title":"Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery","volume":"20","author":"Al-Shawaf","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R34-20250709","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/aas.13170","article-title":"Inotropic and lusitropic effects of levosimendan and milrinone assessed by strain echocardiography-A randomized trial","volume":"62","author":"Fredholm","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"key":"R35-20250709","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13054-017-1848-1","article-title":"Effect of levosimendan on prognosis in adult patients undergoing cardiac surgery: A meta-analysis of randomized, controlled trials","volume":"21","author":"Cheng","year":"2017","journal-title":"Crit Care"},{"key":"R36-20250709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/aca.aca_176_22","article-title":"Levosimendan in right ventricular dysfunction","volume":"26","author":"Kapoor","year":"2023","journal-title":"Ann Card Anaesth"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_4_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:38Z","timestamp":1786647458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_4_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_4_25","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}